Parveet S. Gandoak
Parveet Singh Gandoak regularly represents multinational corporations and private equity sponsors in a range of corporate transactions, including cross-border mergers and acquisitions, minority and control investments, secondary transactions and capital market offerings. He also advises clients on investments in India, China and Southeast Asia.

Bio

Mr. Gandoak has significant experience across a broad range of industry sectors, including insurance, real estate, health care, transportation, manufacturing, technology, retail and marketing services. He also is experienced in advising U.S. and non-U.S. issuers in capital markets offerings, including initial and secondary equity offerings, Rule 144A private placements and offerings under Regulation S.

Prior to joining Skadden, Mr. Gandoak worked in New York and Hong Kong for other U.S. law firms and spent six months in India on a secondment with a leading Indian law firm. Mr. Gandoak’s experience (including at his previous firms) include advising:

Mergers and Acquisitions

  • Hony Capital as the lead investor in the US$430 million round of financing by WeWork Companies Inc.;
  • Capital International in its US$200 million acquisition of a minority stake in Mankind Pharma, an Indian pharmaceutical company;
  • Russia China Investment Fund in its investment in TutorGroup;
  • Clearwater Capital Partners in the establishment of an Indian credit platform, and the US$300 million collective co-investment by Clearwater Capital Partners and two other large global investors;
  • Nereus Capital in its joint venture with Hareon Solar and Treasury Group to invest in solar projects in India;
  • Apollo Global Management in its acquisition of a majority interest in the asset management business of AR Capital (subsequently withdrawn), its acquisition of the wholesale distribution business of RCS Capital and its substantial minority equity investment in RCS Capital;
  • AIF Capital as a selling shareholder in the sale of certain female health care businesses of Famy Care, the world’s largest producer of oral contraceptive pills, to Mylan for US$750 million, with additional contingent payments of up to US$50 million;
  • AXA in the US$335 million sale of its mandatory pension business in Hong Kong to the Principal Financial Group;
  • AIA Group Limited in its landmark exclusive bancassurance partnership with Citibank to distribute its insurance products to 11 countries in the Asia Pacific region. This was the largest-ever bancassurance deal in Asia;
  • HarbourVest in the sale of MYOB, an Australian accounting software firm, for US$1.3 billion to Bain;
  • AIA Group in its US$1.7 billion acquisition of ING’s Malaysian insurance businesses;
  • D. E. Shaw in its joint venture with Reliance Industries to create a broad financial services and investment business in the Indian markets;
  • Exal Corporation in the buyout of Mankind Pharma’s stake in Casablanca Industries and a subscription of shares of Casablanca by Exal India BV;
  • Wyeth in the US$275 million sale of a manufacturing facility and certain pharmaceutical products to Akrimax Pharmaceuticals, LLC; and
  • One Equity Partners, Oak Investment Partners and Rho Ventures in the US$855 million going-private acquisition of Vertrue Inc.

Capital Markets

  • American International Group (AIG) in its US$2 billion sale of ordinary shares of AIA Group Limited;
  • Goldman Sachs, Citi and Credit Suisse as bookrunning managers for the US$6.4 billion combined primary and secondary offerings of common stock by MetLife and AIG;
  • Interactive Brokers Group in its US$1.3 billion IPO; and
  • Citi, RBC and Standard Bank as joint book-running managers in Columbus International’s Rule 144A/Regulation S placement of US$450 million senior secured notes.

Mr. Gandoak is a regular speaker at many international private equity and corporate events, and is the recipient of the CALI Excellence for the Future Award for extraordinary achievement in dispute resolution from Cornell Law School.

________________

Skadden, Arps, Slate, Meagher & Flom is licensed in Singapore as a registered foreign law firm to advise clients on certain aspects of their international transactions and operations. We are not authorized to practice Singapore law. All matters relating to advice as to Singapore law will be dealt with by a separate local Singapore law firm.

Credentials

Education

  • LL.M., Cornell Law School, 2006
  • BSL/LL.B., ILS Law College, Pune, 2005

Admissions

  • Hong Kong
  • New York

Parveet S. Gandoak